Query author contributions in Reactome
Reactome depends on collaboration between our curation team and outside experts to assemble and peer-review its pathway modules. The integration of ORCID within Reactome enables us to meet a key challenge with authoring, curating and reviewing biological information by incentivizing and crediting the external experts that contribute their expertise and time to the Reactome curation process. More information is available at ORCID and Reactome.
If you have an ORCID ID that is not listed on this page, please forward this information to us and we will update your Reactome pathway records.
Details on Person Antimicrobial compounds kill microorganisms or inhibit their...
| Class:Id | Summation:9640398 |
|---|---|
| _displayName | Antimicrobial compounds kill microorganisms or inhibit their... |
| _timestamp | 2019-03-26 10:46:06 |
| created | [InstanceEdit:9640397] Pardo, Agustin, 2019-03-26 |
| text | Antimicrobial compounds kill microorganisms or inhibit their growth, either in the host, outside on the skin (antiseptics), or in the environment (disinfectants). In the host they are named after the target symbiont, for example antibiotics, antifungals, and antiparasitics. It suffices to permanently stop an essential pathway in the symbiont to kill it. Broad spectrum antimicrobials usually target a conserved pathway like protein synthesis or cell wall construction, in order to affect a whole taxonomic group (Arenz & Wilson 2016, Barry et al. 2007, Green 2002). Resistance of microorganisms (bacteria, viruses, parasites) to antimicrobials is one of the most important public health problems. Many mechanisms exist, and they are either acquired by mutation, by horizontal gene transfer, or are already intrinsic to the organism. The main mechanisms are modification of the antimicrobial, or its removal from the place of action, modification of its binding partner in the affected pathway, or usage of a back-up pathway. Participation of the organism in a consortium (like in biofilms) enables additional resistance mechanisms (Aminov & Mackie 2007, Peterson & Kaur 2018, van Acker et al. 2014, van Acker & Coenye 2016). The events described here are specific to Mtb infection. |
| (summation) | [Pathway:9639775] Antimicrobial action and antimicrobial resistance in Mtb [Homo sapiens] |
| [Change default viewing format] | |
No pathways have been reviewed or authored by Antimicrobial compounds kill microorganisms or inhibit their... (9640398)
